227 related articles for article (PubMed ID: 24643166)
1. Impact of the adipokine adiponectin and the hepatokine fetuin-A on the development of type 2 diabetes: prospective cohort- and cross-sectional phenotyping studies.
Stefan N; Sun Q; Fritsche A; Machann J; Schick F; Gerst F; Jeppesen C; Joost HG; Hu FB; Boeing H; Ullrich S; Häring HU; Schulze MB
PLoS One; 2014; 9(3):e92238. PubMed ID: 24643166
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of various biomarkers as potential mediators of the association between Δ5 desaturase, Δ6 desaturase, and stearoyl-CoA desaturase activity and incident type 2 diabetes in the European Prospective Investigation into Cancer and Nutrition-Potsdam Study.
Jacobs S; Schiller K; Jansen EH; Boeing H; Schulze MB; Kröger J
Am J Clin Nutr; 2015 Jul; 102(1):155-64. PubMed ID: 25971719
[TBL] [Abstract][Full Text] [Related]
3. Increased fetuin-A concentrations in impaired glucose tolerance with or without nonalcoholic fatty liver disease, but not impaired fasting glucose.
Ou HY; Yang YC; Wu HT; Wu JS; Lu FH; Chang CJ
J Clin Endocrinol Metab; 2012 Dec; 97(12):4717-23. PubMed ID: 23066121
[TBL] [Abstract][Full Text] [Related]
4. Changes Over Time in Hepatic Markers Predict Changes in Insulin Sensitivity, β-Cell Function, and Glycemia.
Pinnaduwage L; Ye C; Hanley AJ; Connelly PW; Sermer M; Zinman B; Retnakaran R
J Clin Endocrinol Metab; 2018 Jul; 103(7):2651-2659. PubMed ID: 29897453
[TBL] [Abstract][Full Text] [Related]
5. Plasma fetuin-A levels and the risk of type 2 diabetes.
Stefan N; Fritsche A; Weikert C; Boeing H; Joost HG; Häring HU; Schulze MB
Diabetes; 2008 Oct; 57(10):2762-7. PubMed ID: 18633113
[TBL] [Abstract][Full Text] [Related]
6. Exercise-induced lowering of fetuin-A may increase hepatic insulin sensitivity.
Malin SK; del Rincon JP; Huang H; Kirwan JP
Med Sci Sports Exerc; 2014 Nov; 46(11):2085-90. PubMed ID: 24637346
[TBL] [Abstract][Full Text] [Related]
7. Regulation of the novel adipokines/ hepatokines fetuin A and fetuin B in gestational diabetes mellitus.
Kralisch S; Hoffmann A; Lössner U; Kratzsch J; Blüher M; Stumvoll M; Fasshauer M; Ebert T
Metabolism; 2017 Mar; 68():88-94. PubMed ID: 28183456
[TBL] [Abstract][Full Text] [Related]
8. Fetuin-A and risk of diabetes-related vascular complications: a prospective study.
Birukov A; Polemiti E; Jäger S; Stefan N; Schulze MB
Cardiovasc Diabetol; 2022 Jan; 21(1):6. PubMed ID: 34998417
[TBL] [Abstract][Full Text] [Related]
9. Association of fetuin-A with incident type 2 diabetes: results from the MONICA/KORA Augsburg study and a systematic meta-analysis.
Sujana C; Huth C; Zierer A; Meesters S; Sudduth-Klinger J; Koenig W; Herder C; Peters A; Thorand B
Eur J Endocrinol; 2018 Apr; 178(4):389-398. PubMed ID: 29439057
[TBL] [Abstract][Full Text] [Related]
10. Prospective Relation of Circulating Adipokines to Incident Metabolic Syndrome: The Framingham Heart Study.
Zachariah JP; Quiroz R; Nelson KP; Teng Z; Keaney JF; Sullivan LM; Vasan RS
J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28713076
[TBL] [Abstract][Full Text] [Related]
11. Kinetics of circulating fetuin-A may predict mortality independently from adiponectin, high molecular weight adiponectin and prognostic factors in critically ill patients with sepsis: A prospective study.
Karampela I; Kandri E; Antonakos G; Vogiatzakis E; Christodoulatos GS; Nikolaidou A; Dimopoulos G; Armaganidis A; Dalamaga M
J Crit Care; 2017 Oct; 41():78-85. PubMed ID: 28500919
[TBL] [Abstract][Full Text] [Related]
12. Higher fetuin-A, lower adiponectin and free leptin levels mediate effects of excess body weight on insulin resistance and risk for myelodysplastic syndrome.
Dalamaga M; Karmaniolas K; Chamberland J; Nikolaidou A; Lekka A; Dionyssiou-Asteriou A; Mantzoros CS
Metabolism; 2013 Dec; 62(12):1830-9. PubMed ID: 24140093
[TBL] [Abstract][Full Text] [Related]
13. The relationship of circulating fetuin-a with liver histology and biomarkers of systemic inflammation in nondiabetic subjects with nonalcoholic fatty liver disease.
Celebi G; Genc H; Gurel H; Sertoglu E; Kara M; Tapan S; Acikel C; Karslioglu Y; Ercin CN; Dogru T
Saudi J Gastroenterol; 2015; 21(3):139-45. PubMed ID: 26021772
[TBL] [Abstract][Full Text] [Related]
14. Interaction between plasma fetuin-A and free fatty acids predicts changes in insulin sensitivity in response to long-term exercise.
Lee S; Norheim F; Gulseth HL; Langleite TM; Kolnes KJ; Tangen DS; Stadheim HK; Gilfillan GD; Holen T; Birkeland KI; Jensen J; Drevon CA
Physiol Rep; 2017 Mar; 5(5):. PubMed ID: 28270597
[TBL] [Abstract][Full Text] [Related]
15. Serum fetuin-A concentrations are elevated in subjects with impaired glucose tolerance and newly diagnosed type 2 diabetes.
Ou HY; Yang YC; Wu HT; Wu JS; Lu FH; Chang CJ
Clin Endocrinol (Oxf); 2011 Oct; 75(4):450-5. PubMed ID: 21521338
[TBL] [Abstract][Full Text] [Related]
16. Sex-specific association of fetuin-A with type 2 diabetes in older community-dwelling adults: the Rancho Bernardo study.
Laughlin GA; Barrett-Connor E; Cummins KM; Daniels LB; Wassel CL; Ix JH
Diabetes Care; 2013 Jul; 36(7):1994-2000. PubMed ID: 23315604
[TBL] [Abstract][Full Text] [Related]
17. Fibroblast Growth Factor 21 and Fetuin-A in Obese Adolescents With and Without Type 2 Diabetes.
Reinehr T; Karges B; Meissner T; Wiegand S; Fritsch M; Holl RW; Woelfle J
J Clin Endocrinol Metab; 2015 Aug; 100(8):3004-10. PubMed ID: 26052728
[TBL] [Abstract][Full Text] [Related]
18. Inflammatory Markers in Obese Adolescents with Type 2 Diabetes and Their Relationship to Hepatokines and Adipokines.
Reinehr T; Karges B; Meissner T; Wiegand S; Stoffel-Wagner B; Holl RW; Woelfle J
J Pediatr; 2016 Jun; 173():131-5. PubMed ID: 26996723
[TBL] [Abstract][Full Text] [Related]
19. Circulating Fetuin-A and Risk of Type 2 Diabetes: A Mendelian Randomization Analysis.
Kröger J; Meidtner K; Stefan N; Guevara M; Kerrison ND; Ardanaz E; Aune D; Boeing H; Dorronsoro M; Dow C; Fagherazzi G; Franks PW; Freisling H; Gunter MJ; Huerta JM; Kaaks R; Key TJ; Khaw KT; Krogh V; Kühn T; Mancini FR; Mattiello A; Nilsson PM; Olsen A; Overvad K; Palli D; Quirós JR; Rolandsson O; Sacerdote C; Sala N; Salamanca-Fernández E; Sluijs I; Spijkerman AMW; Tjonneland A; Tsilidis KK; Tumino R; van der Schouw YT; Forouhi NG; Sharp SJ; Langenberg C; Riboli E; Schulze MB; Wareham NJ
Diabetes; 2018 Jun; 67(6):1200-1205. PubMed ID: 29523632
[TBL] [Abstract][Full Text] [Related]
20. No Independent Association of Circulating Fetuin-A with Insulin Sensitivity in Young Women.
Reif S; Moschko S; Gar C; Ferrari U; Hesse N; Sommer NN; Seißler J; Lechner A
Horm Metab Res; 2020 Nov; 52(11):809-814. PubMed ID: 32767281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
